---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-050498"
form_type: "8-K"
ticker: "XWEL"
cik: "0001410428"
company_name: "XWELL, Inc."
filed_at: "2025-05-19T23:59:59+00:00"
generated_at: "2026-05-21T01:25:00.962172+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# XWELL (XWEL) receives Nasdaq minimum bid price deficiency notice; cure period to Nov 10, 2025

## Summary
- Nasdaq notified XWELL on May 13, 2025 that its common stock's closing bid price was below $1.00 for 30 consecutive business days (Mar 31 - May 12, 2025).
- Company has 180 calendar days, until November 10, 2025, to regain compliance by maintaining a $1.00 closing bid for at least ten consecutive business days.
- If not compliant by Nov 10, XWELL may qualify for an additional 180-day period if it meets all other Nasdaq Capital Market initial listing standards.
- There can be no assurance of eligibility for an additional cure period or that Nasdaq will grant continued listing if delisting proceedings begin.
- The notice has no immediate impact on listing; XWELL's common stock continues to trade on Nasdaq pending compliance with other requirements.

## SEC filing metadata
- accession: 0001104659-25-050498
- form_type: 8-K
- ticker: XWEL
- cik: 0001410428
- company_name: XWELL, Inc.
- filed_at: 2025-05-19T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1410428/000110465925050498/0001104659-25-050498-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1410428/000110465925050498/tm2515209d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-050498
- JSON: https://secwatch.observer/filing/0001104659-25-050498.json
- Plain text: https://secwatch.observer/filing/0001104659-25-050498.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
